Table 1.
Baseline patient characteristics (N=35)
| Characteristic | Frequency |
|---|---|
| Enrollment location | |
| United States | 23 (66%) |
| Pacific | 12 (34%) |
| Median age (Range) | 61 yrs (21–77) |
| ECOG performance status | |
| 0 | 11 (31%) |
| 1 | 23 (66%) |
| 2 | 1 (3%) |
| Male | 28 (80%) |
| Race | |
| Asian | 14 (40%) |
| White | 19 (54%) |
| Black or African American | 1 (3%) |
| Unknown | 1 (3%) |
| Primary disease site—Hepatic | 31 (89%) |
| Locally advanced (vs Metastatic) | 17 (49%) |
| Viral hepatitis | 16 (46%) |
| History of chronic hepatitis | 16 (46%) |
| Pathology | |
| Hepatocellular | 32 (92%) |
| Other | 3 (8%) |
| Child-Pugh’s classification | |
| A | 29 (85%) |
| B | 5 (15%) |
| Prior Therapy | 7 (20%) |
| Types of prior therapy | |
| Chemoembolization | 4 (57%) |
| Surgical resection | 1 (14%) |
| Chemoembolization & radiofrequency | |
| ablation | 1 (14%) |
| Surgical resection & radiofrequency | |
| ablation | 1 (14%) |